TransCode Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 12.74 K | $109.69 K | 100.00% | 1.39% |
| UBS GROUP AG | 05/05/2026 | 8.30 K | $71.42 K | 179.86% | 0.90% |
| 05/15/2026 | 6.55 K | $56.35 K | 100.00% | 0.71% | |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 2.98 K | $25.68 K | 100.00% | 0.33% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 228 | $1.96 K | -74.30% | 0.02% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 55 | $474 | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 12 | $103 | 20.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TransCode Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 10 institutional investors and hedge funds held shares of TransCode Therapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 12,740
UBS Group AG: 8,295
VANGUARD FIDUCIARY TRUST CO: 2,982
Tower Research Capital LLC (TRC): 228
WELLS FARGO & COMPANY/MN: 55
SBI Securities Co., Ltd.: 12
3.37% of TransCode Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 24.31 K shares in the last 24 months. This purchase volume represents approximately $235.10 K in transactions.